237
Views
73
CrossRef citations to date
0
Altmetric
Review

Antioxidant approaches for the treatment of Alzheimer’s disease

, , , , , , & show all
Pages 1201-1208 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Francesco Panza, Vincenzo Solfrizzi, Bruno P Imbimbo & Giancarlo Logroscino. (2014) Amyloid-directed monoclonal antibodies for the treatment of Alzheimer’s disease: the point of no return?. Expert Opinion on Biological Therapy 14:10, pages 1465-1476.
Read now

Articles from other publishers (72)

Abdul Jalil Shah, Prince Ahad Mir, Mohd Adnan, Mitesh Patel, Mudasir Maqbool, Reyaz Hassan Mir & Mubashir Hussain Masoodi. (2023) Synthetic and Natural Bioactive Molecules in Balancing the Crosstalk among Common Signaling Pathways in Alzheimer’s Disease: Understanding the Neurotoxic Mechanisms for Therapeutic Intervention. ACS Omega 8:43, pages 39964-39983.
Crossref
Clayton A. Whitmore, Justin R. Haynes, William J. Behof, Adam J. Rosenberg, Mohammed N. Tantawy, Brian C. Hachey, Brian E. Wadzinski, Benjamin W. Spiller, Todd E. Peterson, Krista C. Paffenroth, Fiona E. Harrison, Robert B. Beelman, Printha Wijesinghe, Joanne A. Matsubara & Wellington Pham. (2022) Longitudinal Consumption of Ergothioneine Reduces Oxidative Stress and Amyloid Plaques and Restores Glucose Metabolism in the 5XFAD Mouse Model of Alzheimer’s Disease. Pharmaceuticals 15:6, pages 742.
Crossref
Maria Laura Ontario, Rosalba Siracusa, Sergio Modafferi, Maria Scuto, Sebastiano Sciuto, Valentina Greco, Maria Paola Bertuccio, Angela Trovato Salinaro, Roberto Crea, Edward J. Calabrese, Rosanna Di Paola & Vittorio Calabrese. (2022) Potential prevention and treatment of neurodegenerative disorders by olive polyphenols and hidrox. Mechanisms of Ageing and Development 203, pages 111637.
Crossref
Hailin Zheng, Tamar Amit, Orit Bar-Am, Mati Fridkin, Silvia A. Mandel & Moussa B. H. Youdim. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 3167 3192 .
Milica Aćimović, Jovana Ljujić, Jelena Vulić, Valtcho D. Zheljazkov, Lato Pezo, Ana Varga & Vesna Tumbas Šaponjac. (2021) Helichrysum italicum (Roth) G. Don Essential Oil from Serbia: Chemical Composition, Classification and Biological Activity—May It Be a Suitable New Crop for Serbia?. Agronomy 11:7, pages 1282.
Crossref
AnnieJessica Toppo & Sheela Chandra. (2021) Antioxidant and antiacetylcholinestrase studies of In vitro regenerated and transformed hairy roots of Ocimum sanctum (L.). Pharmacognosy Magazine 17:6, pages 151.
Crossref
Md. Sahab Uddin, Abdullah Al Mamun, Md. Tanvir Kabir, Ghulam Md Ashraf, May N. Bin-Jumah & Mohamed M. Abdel-Daim. (2020) Multi-Target Drug Candidates for Multifactorial Alzheimer’s Disease: AChE and NMDAR as Molecular Targets. Molecular Neurobiology 58:1, pages 281-303.
Crossref
Enric Bufill, Roser Ribosa-Nogué & Rafael Blesa. 2020. Alzheimer’s Disease: Drug Discovery. Alzheimer’s Disease: Drug Discovery 151 164 .
Tuba Acet, Kadriye Ozcan & Gokhan Zengin. (2019) An assessment of phenolic profiles, fatty acid compositions, and biological activities of two Helichrysum species: H. plicatum and H. chionophilum . Journal of Food Biochemistry 44:2.
Crossref
Hailin Zheng, Tamar Amit, Orit Bar-Am, Mati Fridkin, Silvia A. Mandel & Moussa B. H. Youdim. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 26 .
Eva Mezeiova, Katarina Chalupova, Eugenie Nepovimova, Lukas Gorecki, Lukas Prchal, David Malinak, Kamil Kuca, Ondrej Soukup & Jan Korabecny. (2019) Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease. Current Alzheimer Research 16:9, pages 772-800.
Crossref
Xiao-Long Shi, Jing-De Wu, Ping Liu & Zhao-Peng Liu. (2019) Synthesis and evaluation of novel GSK-3β inhibitors as multifunctional agents against Alzheimer's disease. European Journal of Medicinal Chemistry 167, pages 211-225.
Crossref
Yixiang Xu, Jian Zhang, Huan Wang, Fei Mao, Keting Bao, Wenwen Liu, Jin Zhu, Xiaokang Li, Haiyan Zhang & Jian Li. (2018) Rational Design of Novel Selective Dual-Target Inhibitors of Acetylcholinesterase and Monoamine Oxidase B as Potential Anti-Alzheimer’s Disease Agents. ACS Chemical Neuroscience 10:1, pages 482-496.
Crossref
Giuseppe Tardiolo, Placido Bramanti & Emanuela Mazzon. (2018) Overview on the Effects of N-Acetylcysteine in Neurodegenerative Diseases. Molecules 23:12, pages 3305.
Crossref
Maria S. Aymerich, Ester Aso, Miguel A. Abellanas, Rosa M. Tolon, Jose A. Ramos, Isidre Ferrer, Julian Romero & Javier Fernández-Ruiz. (2018) Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system. Biochemical Pharmacology 157, pages 67-84.
Crossref
Yi-xiang Xu, Huan Wang, Xiao-kang Li, Sheng-nan Dong, Wen-wen Liu, Qi Gong, Tian-duan-yi Wang, Yun Tang, Jin Zhu, Jian Li, Hai-yan Zhang & Fei Mao. (2018) Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry 143, pages 33-47.
Crossref
Noriko Shinjyo & Julia Green. (2017) Are sage, rosemary and lemon balm effective interventions in dementia? A narrative review of the clinical evidence. European Journal of Integrative Medicine 15, pages 83-96.
Crossref
Eeda Koti Reddy, Chandran Remya, Kumar Mantosh, Ayyiliath M. Sajith, R.V. Omkumar, C. Sadasivan & Shaik Anwar. (2017) Novel tacrine derivatives exhibiting improved acetylcholinesterase inhibition: Design, synthesis and biological evaluation. European Journal of Medicinal Chemistry 139, pages 367-377.
Crossref
Manuela Pennisi, Rosalia Crupi, Rosanna Di Paola, Maria Laura Ontario, Rita Bella, Edward J. Calabrese, Roberto Crea, Salvatore Cuzzocrea & Vittorio Calabrese. (2017) Inflammasomes, hormesis, and antioxidants in neuroinflammation: Role of NRLP3 in Alzheimer disease. Journal of Neuroscience Research 95:7, pages 1360-1372.
Crossref
Nicolas Farina, David Llewellyn, Mokhtar Gad El Kareem Nasr Isaac & Naji Tabet. (2017) Vitamin E for Alzheimer's dementia and mild cognitive impairment. Cochrane Database of Systematic Reviews 2017:4.
Crossref
Bilqees Sameem, Mina Saeedi, Mohammad Mahdavi & Abbas Shafiee. (2017) A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease. European Journal of Medicinal Chemistry 128, pages 332-345.
Crossref
Nicolas Farina, David Llewellyn, Mokhtar Gad El Kareem Nasr Isaac & Naji Tabet. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Sandra Gonçalves, Elsa Moreira, Clara Grosso, Paula B. Andrade, Patrícia Valentão & Anabela Romano. (2016) Phenolic profile, antioxidant activity and enzyme inhibitory activities of extracts from aromatic plants used in Mediterranean diet. Journal of Food Science and Technology 54:1, pages 219-227.
Crossref
Chengli Yu, Jing Gao, Yanting Zhou, Xiangling Chen, Ruoxuan Xiao, Jing Zheng, Yansheng Liu & Hu Zhou. (2016) Deep Phosphoproteomic Measurements Pinpointing Drug Induced Protective Mechanisms in Neuronal Cells. Frontiers in Physiology 7.
Crossref
Xiaokang Li, Huan Wang, Zhengyu Lu, Xinyu Zheng, Wei Ni, Jin Zhu, Yan Fu, Fulin Lian, Naixia Zhang, Jian Li, Haiyan Zhang & Fei Mao. (2016) Development of Multifunctional Pyrimidinylthiourea Derivatives as Potential Anti-Alzheimer Agents. Journal of Medicinal Chemistry 59:18, pages 8326-8344.
Crossref
José Marco-Contelles, Mercedes Unzeta, Irene Bolea, Gerard Esteban, Rona R. Ramsay, Alejandro Romero, Ricard Martínez-Murillo, M. Carmo Carreiras & Lhassane Ismaili. (2016) ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy. Frontiers in Neuroscience 10.
Crossref
A. Cardone, M. Brady, R. Sriram, H. C. Pant & S. A. Hassan. (2016) Computational study of the inhibitory mechanism of the kinase CDK5 hyperactivity by peptide p5 and derivation of a pharmacophore. Journal of Computer-Aided Molecular Design 30:6, pages 513-521.
Crossref
Mercedes Unzeta, Gerard Esteban, Irene Bolea, Wieslawa A. Fogel, Rona R. Ramsay, Moussa B. H. Youdim, Keith F. Tipton & José Marco-Contelles. (2016) Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease. Frontiers in Neuroscience 10.
Crossref
Barbora Cervinkova, Lenka Kujovska Krcmova, Dagmar Solichova, Bohuslav Melichar & Petr Solich. (2016) Recent advances in the determination of tocopherols in biological fluids: from sample pretreatment and liquid chromatography to clinical studies. Analytical and Bioanalytical Chemistry 408:10, pages 2407-2424.
Crossref
Valerio Chiurchiù, Antonio Orlacchio & Mauro Maccarrone. (2016) Is Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative Diseases. Oxidative Medicine and Cellular Longevity 2016, pages 1-11.
Crossref
Quan Feng Liu, Haemin Jeong, Jang Ho Lee, Yoon Ki Hong, Youngje Oh, Young-Mi Kim, Yoon Seok Suh, Semin Bang, Hye Sup Yun, Kyungho Lee, Sung Man Cho, Sung Bae Lee, Songhee Jeon, Young-Won Chin, Byung-Soo Koo & Kyoung Sang Cho. (2016) Coriandrum sativum Suppresses Aβ42-Induced ROS Increases, Glial Cell Proliferation, and ERK Activation . The American Journal of Chinese Medicine 44:07, pages 1325-1347.
Crossref
Michel Baudry & Bernard Malfroy-Camine. 2016. Inflammation, Aging, and Oxidative Stress. Inflammation, Aging, and Oxidative Stress 241 259 .
Pedro Cisternas, Carolina B. Lindsay, Paulina Salazar, Carmen Silva-Alvarez, Rocio M. Retamales, Felipe G. Serrano, Carlos P. Vio & Nibaldo C. Inestrosa. (2015) The increased potassium intake improves cognitive performance and attenuates histopathological markers in a model of Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1852:12, pages 2630-2644.
Crossref
Eugenie Nepovimova, Jan Korabecny, Rafael Dolezal, Katerina Babkova, Ales Ondrejicek, Daniel Jun, Vendula Sepsova, Anna Horova, Martina Hrabinova, Ondrej Soukup, Neslihan Bukum, Petr Jost, Lubica Muckova, Jiri Kassa, David Malinak, Martin Andrs & Kamil Kuca. (2015) Tacrine–Trolox Hybrids: A Novel Class of Centrally Active, Nonhepatotoxic Multi-Target-Directed Ligands Exerting Anticholinesterase and Antioxidant Activities with Low In Vivo Toxicity. Journal of Medicinal Chemistry 58:22, pages 8985-9003.
Crossref
Nibaldo C. Inestrosa, Juvenal A. Ríos, Pedro Cisternas, Cheril Tapia-Rojas, Daniela S. Rivera, Nady Braidy, Juan M. Zolezzi, Juan A. Godoy, Francisco J. Carvajal, Alvaro O. Ardiles, Francisco Bozinovic, Adrián G. Palacios & Perminder S. Sachdev. (2015) Age Progression of Neuropathological Markers in the Brain of the Chilean Rodent Octodon degus , a Natural Model of Alzheimer's Disease . Brain Pathology 25:6, pages 679-691.
Crossref
Mi Hye Kim, Ji Yeon Seo & Jong-Sang Kim. (2015) Artemisia annua L. extract ameliorates galactose-induced cognitive impairment in mice. Food Science and Biotechnology 24:5, pages 1901-1905.
Crossref
Sai-Sai Xie, Jin-Shuai Lan, Xiao-Bing Wang, Neng Jiang, Ge Dong, Zhong-Rui Li, Kelvin D.G. Wang, Ping-Ping Guo & Ling-Yi Kong. (2015) Multifunctional tacrine–trolox hybrids for the treatment of Alzheimer's disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties. European Journal of Medicinal Chemistry 93, pages 42-50.
Crossref
Natalie A. Grima & Matthew P. Pase. 2015. Diet and Nutrition in Dementia and Cognitive Decline. Diet and Nutrition in Dementia and Cognitive Decline 819 825 .
Juan A Godoy, Juvenal A Rios, Juan M Zolezzi, Nady Braidy & Nibaldo C Inestrosa. (2014) Signaling pathway cross talk in Alzheimer’s disease. Cell Communication and Signaling 12:1.
Crossref
N. El Kadmiri, I. Slassi, B. El Moutawakil, S. Nadifi, A. Tadevosyan, A. Hachem & A. Soukri. (2014) Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease. Pathologie Biologie 62:6, pages 333-336.
Crossref
Juan M. Zolezzi & Nibaldo C. Inestrosa. (2014) Brain metabolite clearance: impact on Alzheimer’s disease. Metabolic Brain Disease 29:3, pages 553-561.
Crossref
Elina M. Sutinen, Minna A. Korolainen, Jukka Häyrinen, Irina Alafuzoff, Steven Petratos, Antero Salminen, Hilkka Soininen, Tuula Pirttilä & Johanna O. Ojala. (2014) Interleukin-18 alters protein expressions of neurodegenerative diseases-linked proteins in human SH-SY5Y neuron-like cells. Frontiers in Cellular Neuroscience 8.
Crossref
Y. -H. Yang, T. -J. Hsieh, M. -L. Tsai, C. -H. Chen, H. -T. Lin & Shyh-Jong Wu. (2013) Neuroprotective effects of Hu-Yi-Neng, a diet supplement, On SH-SY5Y human neuroblastoma cells. The journal of nutrition, health & aging 18:2, pages 184-190.
Crossref
Hailin Zheng, Mati Fridkin & Moussa Youdim. (2014) From Single Target to Multitarget/Network Therapeutics in Alzheimer’s Therapy. Pharmaceuticals 7:2, pages 113-135.
Crossref
Sanda Vladimir-Knežević, Biljana Blažeković, Marija Kindl, Jelena Vladić, Agnieszka Lower-Nedza & Adelheid Brantner. (2014) Acetylcholinesterase Inhibitory, Antioxidant and Phytochemical Properties of Selected Medicinal Plants of the Lamiaceae Family. Molecules 19:1, pages 767-782.
Crossref
Etsuo Niki. (2014) Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence. Free Radical Biology and Medicine 66, pages 3-12.
Crossref
Sally Hunter, Thomas Arendt & Carol Brayne. (2013) The Senescence Hypothesis of Disease Progression in Alzheimer Disease: an Integrated Matrix of Disease Pathways for FAD and SAD. Molecular Neurobiology 48:3, pages 556-570.
Crossref
Tao Su, Shishun Xie, Hui Wei, Jun Yan, Ling Huang & Xingshu Li. (2013) Synthesis and biological evaluation of berberine–thiophenyl hybrids as multi-functional agents: Inhibition of acetylcholinesterase, butyrylcholinesterase, and Aβ aggregation and antioxidant activity. Bioorganic & Medicinal Chemistry 21:18, pages 5830-5840.
Crossref
Said AbdAlla, Andreas Langer, Xuebin Fu & Ursula Quitterer. (2013) ACE Inhibition with Captopril Retards the Development of Signs of Neurodegeneration in an Animal Model of Alzheimer’s Disease. International Journal of Molecular Sciences 14:8, pages 16917-16942.
Crossref
Gui-lian Zhang, Wang-gang Zhang, Yun Du, Li Yao, Hong Sun, Ru Zhang, Enqi Liu, Ning Bu, Hai-qin Wu, Lei Zhang, Ting-ting Li & Ying-ying Guo. (2013) Edaravone Ameliorates Oxidative Damage Associated with Aβ25-35 Treatment in PC12 Cells. Journal of Molecular Neuroscience 50:3, pages 494-503.
Crossref
Alberto M. Hernández-Pinto, Lilian Puebla-Jiménez, Aránzazu Perianes-Cachero & Eduardo Arilla-Ferreiro. (2013) Vitamin E deficiency impairs the somatostatinergic receptor–effector system and leads to phosphotyrosine phosphatase overactivation and cell death in the rat hippocampus. The Journal of Nutritional Biochemistry 24:5, pages 848-858.
Crossref
Subhashini Bolisetty & Edgar Jaimes. (2013) Mitochondria and Reactive Oxygen Species: Physiology and Pathophysiology. International Journal of Molecular Sciences 14:3, pages 6306-6344.
Crossref
Varsha Shukla, Ya‐Li Zheng, Santosh K. Mishra, Niranjana D. Amin, Joseph Steiner, Philip Grant, Sashi Kesavapany & Harish C. Pant. (2012) A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice. The FASEB Journal 27:1, pages 174-186.
Crossref
Li Na Zhao, Tong Zhang, Ce Zhang, Chao Wang, Ludmilla A. Morozova-Roche, Lock Yue Chew & Yuguang Mu. (2013) S100A9 induces aggregation-prone conformation in Abeta peptides: a combined experimental and simulation study. RSC Advances 3:46, pages 24081.
Crossref
Sönke Arlt, Tomas Müller-Thomsen, Ulrike Beisiegel & Anatol Kontush. (2012) Effect of One-Year Vitamin C- and E-Supplementation on Cerebrospinal Fluid Oxidation Parameters and Clinical Course in Alzheimer’s Disease. Neurochemical Research 37:12, pages 2706-2714.
Crossref
Nicolas Farina, Mokhtar Gad El Kareem Nasr Isaac, Annalie R Clark, Jennifer Rusted & Naji Tabet. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Andreas Schrötter, Kathy Pfeiffer, Fouzi El Magraoui, Harald W. Platta, Ralf Erdmann, Helmut E. Meyer, Rupert Egensperger, Katrin Marcus & Thorsten Müller. (2012) The Amyloid Precursor Protein (APP) Family Members are Key Players in S-adenosylmethionine Formation by MAT2A and Modify BACE1 and PSEN1 Gene Expression-Relevance for Alzheimer's Disease. Molecular & Cellular Proteomics 11:11, pages 1274-1288.
Crossref
Virawudh Soontornniyomkij, Benchawanna Soontornniyomkij, David J. Moore, Ben Gouaux, Eliezer Masliah, Spencer Tung, Harry V. Vinters, Igor Grant & Cristian L. Achim. (2012) Antioxidant Sestrin-2 Redistribution to Neuronal Soma in Human Immunodeficiency Virus-Associated Neurocognitive Disorders. Journal of Neuroimmune Pharmacology 7:3, pages 579-590.
Crossref
Micha M.M. Wilhelmus, Philip G. Nijland, Benjamin Drukarch, Helga E. de Vries & Jack van Horssen. (2012) Involvement and interplay of Parkin, PINK1, and DJ1 in neurodegenerative and neuroinflammatory disorders. Free Radical Biology and Medicine 53:4, pages 983-992.
Crossref
Darren Cotterell & Martin Brown. 2012. Essential Evidence-Based Psychopharmacology. Essential Evidence-Based Psychopharmacology 262 277 .
Silvia Sorce, Karl-Heinz Krause & Vincent Jaquet. (2012) Targeting NOX enzymes in the central nervous system: therapeutic opportunities. Cellular and Molecular Life Sciences 69:14, pages 2387-2407.
Crossref
Gary Fiskum & Melissa Laird. 2012. Mitochondrial Signaling in Health and Disease. Mitochondrial Signaling in Health and Disease 469 492 .
Yadong Huang & Lennart Mucke. (2012) Alzheimer Mechanisms and Therapeutic Strategies. Cell 148:6, pages 1204-1222.
Crossref
E. Patterson, R. Wall, G. F. Fitzgerald, R. P. Ross & C. Stanton. (2012) Health Implications of High Dietary Omega-6 Polyunsaturated Fatty Acids. Journal of Nutrition and Metabolism 2012, pages 1-16.
Crossref
Valerio ChiurchiùMauro Maccarrone. (2011) Chronic Inflammatory Disorders and Their Redox Control: From Molecular Mechanisms to Therapeutic Opportunities. Antioxidants & Redox Signaling 15:9, pages 2605-2641.
Crossref
Maire E. Percy, Theo P.A. Kruck, Aileen I. Pogue & Walter J. Lukiw. (2011) Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer's disease. Journal of Inorganic Biochemistry 105:11, pages 1505-1512.
Crossref
Caroline CoisneBritta Engelhardt. (2011) Tight Junctions in Brain Barriers During Central Nervous System Inflammation. Antioxidants & Redox Signaling 15:5, pages 1285-1303.
Crossref
Laura Corsinovi, Fiorella Biasi, Giuseppe Poli, Gabriella Leonarduzzi & Gianluca Isaia. (2011) Dietary lipids and their oxidized products in Alzheimer's disease. Molecular Nutrition & Food Research 55:S2, pages S161-SS172.
Crossref
Yuan-Di Xi, Huan-Ling Yu, Wei-Wei Ma, Bing-Jie Ding, Juan Ding, Lin-Hong Yuan, Jin-Fang Feng & Rong Xiao. (2011) Genistein inhibits mitochondrial-targeted oxidative damage induced by beta-amyloid peptide 25–35 in PC12 cells. Journal of Bioenergetics and Biomembranes 43:4, pages 399-407.
Crossref
Ira T. Lott, Eric Doran, Vinh Q. Nguyen, Anne Tournay, Elizabeth Head & Daniel L. Gillen. (2011) Down syndrome and dementia: A randomized, controlled trial of antioxidant supplementation. American Journal of Medical Genetics Part A 155:8, pages 1939-1948.
Crossref
Alberto Granzotto & Paolo Zatta. (2011) Resveratrol Acts Not through Anti-Aggregative Pathways but Mainly via Its Scavenging Properties against Aβ and Aβ-Metal Complexes Toxicity. PLoS ONE 6:6, pages e21565.
Crossref
Aarthi Narayanan, Taissia Popova, Michael Turell, Jessica Kidd, Jessica Chertow, Serguei G. Popov, Charles Bailey, Fatah Kashanchi & Kylene Kehn-Hall. (2011) Alteration in Superoxide Dismutase 1 Causes Oxidative Stress and p38 MAPK Activation Following RVFV Infection. PLoS ONE 6:5, pages e20354.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.